| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/23/2006 | WO2004019876A3 Conjoint administration of morphogens and ace inhibitors in treatment of chronic renal failure |
| 03/23/2006 | US20060063944 Estrone derivatives and process for producing same |
| 03/23/2006 | US20060063942 Mitotic kinesin inhibitors |
| 03/23/2006 | US20060063940 3-(arylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 03/23/2006 | US20060063937 pathogenic form of amyloid beta polypeptides inhibitor; 2-(2-Fluoro-1,1'-biphenyl-4-yl)-2-methylpropanoic acid; nonsteroidal antiinflammatory agent, neuroprotectant, ; side effect reduction; cyclooxygenase inhibitor; Alzheimer's disease, cognition activator, neurogenerative disease |
| 03/23/2006 | US20060063935 (4S)-3-((E)-2-butenoyl-4-benzyl-2-oxazolidinone;antocarcinogenic agent; controlling progression of cancer through metastasis in animal suffering from a colon, lung, or breast cancer; synergistic mixture with other chemotherapeutic agent or radiation |
| 03/23/2006 | US20060063934 Pyrazole compounds |
| 03/23/2006 | US20060063933 Process for production of carebastine |
| 03/23/2006 | US20060063932 Aminoalkylpyrrolidine serotonin receptor ligands and compositions, their pharmaceutical uses, and methods for their synthesis |
| 03/23/2006 | US20060063931 Compounds, methods and compositions useful for the treatment of bovine viral diarrhea virus (BVDV) infection and hepatitis C virus (HCV) infection |
| 03/23/2006 | US20060063843 Compounds for the treatment of inflammatory disorders |
| 03/23/2006 | US20060063842 Hypogastric and/or perineal pain-relieving agent |
| 03/23/2006 | US20060063840 Use of a specific cyclic amine derivative or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure |
| 03/23/2006 | US20060063839 Inhibitors of decrease in body temperature |
| 03/23/2006 | US20060063838 Activators of peroxisome proliferator-activated receptors |
| 03/23/2006 | US20060063837 Stabilized leukotriene B4 (LTB4) agent pharmaceutical formulation |
| 03/23/2006 | US20060063836 Method for treating renal disease |
| 03/23/2006 | US20060063835 Composition based on triethyl citrate for the treatment of bacterial infections of the skin |
| 03/23/2006 | US20060063834 Substituted adamantanes, and methods of making the same |
| 03/23/2006 | US20060063833 Ready-to-use oxaliplatin solutions |
| 03/23/2006 | US20060063832 Pharmaceutical composition containing platinum complex as active substance and method of manufacturing thereof |
| 03/23/2006 | US20060063831 Composition of labdane diterpenes extracted from andrographis paniculata, ufeful for the treatment of autoimmune diseases, and alzheimer disease by activation for ppr-gamma receptors |
| 03/23/2006 | US20060063830 Method for treating gastrointestinal disorder |
| 03/23/2006 | US20060063828 1,2-Bis-(substituted-phenyl)-2-propen-1-ones and pharmaceutical compositions thereof |
| 03/23/2006 | US20060063827 Systemic administration of therapeutic amino acids and N-acetylamino acids |
| 03/23/2006 | US20060063826 Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation |
| 03/23/2006 | US20060063825 Crystalline form of a drug |
| 03/23/2006 | US20060063824 Wortmannin analogs and methods of using same in combination with chemotherapeutic agents |
| 03/23/2006 | US20060063823 Inhibitors of 15-lipoxygenase |
| 03/23/2006 | US20060063822 inflammation; diabetes; vascular restenosis; hypertension; asthma; rheumatiod arthritis; osteoarthritis; cancer; and inflammatory bowel disease; thrombosis; atherosclerosis; |
| 03/23/2006 | US20060063821 For therapy and prophylaxis of Hepatitis C viral infection in a mammal |
| 03/23/2006 | US20060063819 Novel imidazolidin-2-one derivatives as selective androgen receptor modulators (SARMS) |
| 03/23/2006 | US20060063818 Hydantoin derivatives and deren verwendung als tace inhibitoren |
| 03/23/2006 | US20060063817 e.g. 8-{2-[1,1-dimethyl-3-(6-methyl-2-oxo-2,3-dihydro-benzimidazol-1-yl)-propylamino]-1-hydroxy-ethyl}-6-hydroxy-4H-benzo[1,4]oxazin-3-one; adrenoreceptor modulator (agonist); respiratory system doseases: COPD, asthma, cystic fibrosis; bronchitis; bronchiectasis; Adult Respiratory Distress Syndrome |
| 03/23/2006 | US20060063816 2-Arylbenzothiazole derivatives |
| 03/23/2006 | US20060063815 Polymorphs of an epothilone analog |
| 03/23/2006 | US20060063814 2-[(S)-2-((S)-2,5-dioxo-4-phenyl-imidazolidin-1-yl)-4-methyl-pentanoylamino]-thiazole-4-carboxylic acid methyl ester; mitogen activated protein/extracellular signal regulated kinase kinase inhibitor; anticarcinogenic agent, cognition activator, nervous and autoimmune system disorders |
| 03/23/2006 | US20060063813 Organic compounds |
| 03/23/2006 | US20060063812 Indole derivatives |
| 03/23/2006 | US20060063811 Pyridinalkyl-aminoalkyl-ih-indole derivatives having an inhibitory action on 5-ht and serotonin reuptake as antidepressants and anxiolytics |
| 03/23/2006 | US20060063810 Combination treatment for impaired motor function in parkinson's disease |
| 03/23/2006 | US20060063809 Tri-substituted heteroaryls and methods of making and using the same |
| 03/23/2006 | US20060063808 using isobutyrate or an isobutyrate equivalent |
| 03/23/2006 | US20060063807 Low molecular weight peptidomimetic growth hormone secretagogues |
| 03/23/2006 | US20060063806 4-(4,5,6-trimethoxy-2-benzaldehyde) coumarin; fungicides, nontoxic |
| 03/23/2006 | US20060063805 Thiazolinone 4-monosubstituted quinolines |
| 03/23/2006 | US20060063804 Thiazolinone 2-substituted quinolines |
| 03/23/2006 | US20060063803 4-Amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds |
| 03/23/2006 | US20060063802 N-methylaspartic acid (NMDA) receptor antagonist such as ketamine; drug screening |
| 03/23/2006 | US20060063801 Anticancer therapeutics; 3-(7-Methoxy-4-oxo-4H-1-benzopyran-2-yl)-1-phenyl-1H-1,4-dihydroquinolin-4-one |
| 03/23/2006 | US20060063800 Use of hydroxamic acid derivatives for the preparation of anti-tumour medicaments |
| 03/23/2006 | US20060063799 Sulfonamide bicyclic compounds |
| 03/23/2006 | US20060063798 Heterocyclic aromatic compounds useful as growth hormone secretagogues |
| 03/23/2006 | US20060063796 Pyrazoles as inhibitors of tumor necrosis factor |
| 03/23/2006 | US20060063795 SNS-595 and methods of using the same |
| 03/23/2006 | US20060063794 Method of attenuating graft rejection |
| 03/23/2006 | US20060063793 Method of inhibiting neurotrophin-receptor binding |
| 03/23/2006 | US20060063792 Substituted morphinans and methods of their use |
| 03/23/2006 | US20060063791 (Spirocyclylamido)aminothiophene compounds |
| 03/23/2006 | US20060063790 drugs such as 1,2,3,4-tetrahydro-2-[[2-(3-methyl-1-piperidinyl)-4-(1-phenylcyclopropyl)-5-pyrimidinyl]carbonyl]-isoquinoline and carriers administered as cognition activators |
| 03/23/2006 | US20060063789 Aminobenzamide derivatives as glycogen synthase kinase 3 beta inhibitors |
| 03/23/2006 | US20060063788 Carbon monoxide dependent guanylyl cyclase modifiers and methods of use |
| 03/23/2006 | US20060063787 Condensed imidazole derivatives |
| 03/23/2006 | US20060063785 Substituted pyrazolo[1,5-a] pyrimidines and process for making same |
| 03/23/2006 | US20060063784 Method of using substituted pyrazolo [1,5-a] pyrimidines |
| 03/23/2006 | US20060063783 Sulphonylpiperidine derivatives containing an alkenyl or alkynyl moiety for use as matrix metalloproteinase inhibitors |
| 03/23/2006 | US20060063782 3-Hetero arylmethoxy ! pyridines and their analogues as p38 map kinase inhibitors |
| 03/23/2006 | US20060063781 Pharmaceutical composition for regeneration of cirrhotic liver |
| 03/23/2006 | US20060063780 Sodium channel blockers |
| 03/23/2006 | US20060063779 Pyridyl inhibitors of hedgehog signalling |
| 03/23/2006 | US20060063778 2(R)-Benzyloxymethyl-4-[4-(4-chloro-phenyl)-piperazin-1-yl]-N-hydroxy-3(S)-(4-methoxy-phenyl)-4-oxo-butyramide; inhibiting matrix metalloproteinase; immunosuppression; neuropathic pain |
| 03/23/2006 | US20060063777 Anti-microbial and anti-fungal shampoo for mammals especially humans and dogs |
| 03/23/2006 | US20060063776 heterocyclic amines such as 1-(4-Chloro-phenyl)-cyclobutyl]-{3-[4-(2-methoxy-phenyl)-piperazin-1-ylmethyl]-piperidin-1-yl}-methanone; used as dopamine, serotonin or norepinephrine transporters; addiction, anxiety, depression, sexual dysfunction, hypertension, migraine, Alzheimer's disease, obesity |
| 03/23/2006 | US20060063775 4-[(2,4-dichloro-phenyl)-phenyl-methyl]-piperazine-1-carboxylic acid benzhydryl-amide; conjugated to polyethylene glycol; analgesic, antidiabetic and anticarcinogenic agent, antidepressant, anxiolytic agent |
| 03/23/2006 | US20060063774 Phosphodiesterase inhibitor compounds and nitric oxide donors |
| 03/23/2006 | US20060063773 (Hydrazido)(amino)thiophene compounds |
| 03/23/2006 | US20060063772 New compounds |
| 03/23/2006 | US20060063771 CCR5 antagonists useful for treating AIDS |
| 03/23/2006 | US20060063770 Nitrogenous heterocyclic compounds |
| 03/23/2006 | US20060063769 Preventives/remedies for urinary disturbance |
| 03/23/2006 | US20060063768 Use of folates for producing a preparation suitable for preventing and treating inflammation and diseases associated with inflammation, especially for influencing the inflammation markers crp and saa |
| 03/23/2006 | US20060063767 Phthalazinone derivatives |
| 03/23/2006 | US20060063766 Use of aryl- and heteroaryl-substituted tetrahydroisoquinolines to block reuptake of norepinephrine, dopamine, and serotonin |
| 03/23/2006 | US20060063765 5-[({[({(2S)-4-[(3,4-dichlorophenyl)methyl]-2-morpholinyl}methyl)amino]carbonyl}amino)methyl]-N-methyl-3-furancarboxamide; free of N-{[4-(3,4-dichlorobenzyl)morpholin-2-yl]methyl}-N'-(2-furylmethyl)urea; CCR3/chemokine recetptor/ antagonists |
| 03/23/2006 | US20060063763 Compounds and methods for modulating CXCR3 function |
| 03/23/2006 | US20060063762 Indole indazole and benzazole derivative |
| 03/23/2006 | US20060063761 Novel benzothiazole compounds and methods of use thereof |
| 03/23/2006 | US20060063760 Hydroxamic acids useful in the treatment of hyper-proliferative disorders |
| 03/23/2006 | US20060063759 e.g. 5-(10,11-Dihydro-dibenzo[a,d]cyclohepten-5-ylidenemethyl)-3H-benzooxazol-2-one; antiinflammatory, antidiabetic agent; electrolytes and water retention modulator; hypotensive, hypoglycemic agent; arrhythmias, myocardial fibrosis, osteoporosis, polyuria, polydipsia, Crohn's disease |
| 03/23/2006 | US20060063758 Neuropeptide Y antagonist; antiarthritc agents; cardiovascular disorders; antidiabetic agents; kidney diseases; eating disorders; obesity |
| 03/23/2006 | US20060063757 Sulfonamide derivatives as antipsychotic agents |
| 03/23/2006 | US20060063756 Janus Kinase JAK2 and JAK3; 4-chloro-6-(3,5-dimethylpiperazin-1-yl)pyrimidine; chemotherapeutic, antiproliferative, antiinflammatory, immunomodulatory agent; allergies, asthma, autoimmune diseases, transplant rejection, rheumatoid arthritis, multiple sclerosis |
| 03/23/2006 | US20060063755 Loxapine analogs and methods of use thereof |
| 03/23/2006 | US20060063754 Methods of treating a sleep disorder |
| 03/23/2006 | US20060063753 Use of nefopam for the treatment of nausea or emesis |
| 03/23/2006 | US20060063752 Bicyclic heterocycles, pharmaceutical compositions containing them, their use, and processes for preparing them |
| 03/23/2006 | US20060063751 Novel fused heterocycles and uses thereof |
| 03/23/2006 | US20060063750 neuroprotectants is used for the treatment and prevention of neurodegenerative disorders, Parkinson's disease; ammonium trichloro(dioxyethylene-O,O')tellurate |
| 03/23/2006 | US20060063749 immunomoderators ; bromo-3-hydroxyandrostan-17-one; antiallergens; rhinitis |
| 03/23/2006 | US20060063748 Methods for treating psychosis associated with interferson-alpha therapy |